Cargando…
Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
BACKGROUND: Diabetic retinopathy (DR) and diabetic macular edema (DME) are potentially blinding, microvascular retinal diseases in people with diabetes mellitus. Preclinical studies support a protective role of the hormone prolactin (PRL) due to its ocular incorporation and conversion to vasoinhibin...
Autores principales: | Robles-Osorio, Ma. Ludivina, García-Franco, Renata, Núñez-Amaro, Carlos D., Mira-Lorenzo, Ximena, Ramírez-Neria, Paulina, Hernández, Wendy, López-Star, Ellery, Bertsch, Thomas, Martínez de la Escalera, Gonzalo, Triebel, Jakob, Clapp, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986911/ https://www.ncbi.nlm.nih.gov/pubmed/29896154 http://dx.doi.org/10.3389/fendo.2018.00242 |
Ejemplares similares
-
OR2806 Levosulpiride-Induced Hyperprolactinemia For The Treatment Of Diabetic Macular Edema: A Phase 2 Pilot Clinical Trial
por: Clapp, Carmen, et al.
Publicado: (2023) -
Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy
por: Nuñez-Amaro, Carlos D., et al.
Publicado: (2020) -
Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited
por: Triebel, Jakob, et al.
Publicado: (2022) -
From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis
por: Triebel, Jakob, et al.
Publicado: (2017) -
Pharmacologic therapies for diabetic retinopathy and diabetic macular edema
por: Rechtman, Ehud, et al.
Publicado: (2007)